vs
Astrana Health, Inc.（ASTH）与Fortrea Holdings Inc.（FTRE）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Fortrea Holdings Inc.的1.4倍（$950.5M vs $660.5M），Astrana Health, Inc.净利率更高（0.7% vs -4.9%，领先5.6%），Astrana Health, Inc.同比增速更快（42.9% vs -5.2%），Fortrea Holdings Inc.自由现金流更多（$121.6M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -0.1%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Fortrea Holdings Inc.是一家总部位于美国北卡罗来纳州达勒姆、注册地为特拉华州的合同研究组织，业务覆盖90个国家，主要服务制药、生物技术和医疗器械行业客户，为相关领域的研发提供专业支持。
ASTH vs FTRE — 直观对比
营收规模更大
ASTH
是对方的1.4倍
$660.5M
营收增速更快
ASTH
高出48.1%
-5.2%
净利率更高
ASTH
高出5.6%
-4.9%
自由现金流更多
FTRE
多$127.5M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $660.5M |
| 净利润 | $6.6M | $-32.5M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | -2.1% |
| 净利率 | 0.7% | -4.9% |
| 营收同比 | 42.9% | -5.2% |
| 净利润同比 | 184.4% | 46.9% |
| 每股收益（稀释后） | $0.12 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFTRE
| Q4 25 | $950.5M | $660.5M | ||
| Q3 25 | $956.0M | $701.3M | ||
| Q2 25 | $654.8M | $710.3M | ||
| Q1 25 | $620.4M | $651.3M | ||
| Q4 24 | $665.2M | $697.0M | ||
| Q3 24 | $478.7M | $674.9M | ||
| Q2 24 | $486.3M | $662.4M | ||
| Q1 24 | $404.4M | $662.1M |
净利润ASTHFTRE
| Q4 25 | $6.6M | $-32.5M | ||
| Q3 25 | $373.0K | $-15.9M | ||
| Q2 25 | $9.4M | $-374.9M | ||
| Q1 25 | $6.7M | $-562.9M | ||
| Q4 24 | $-7.8M | $-61.2M | ||
| Q3 24 | $16.1M | $-27.9M | ||
| Q2 24 | $19.2M | $-138.4M | ||
| Q1 24 | $14.8M | $-101.0M |
营业利润率ASTHFTRE
| Q4 25 | 1.9% | -2.1% | ||
| Q3 25 | 2.0% | -1.2% | ||
| Q2 25 | 3.1% | -46.5% | ||
| Q1 25 | 3.3% | -79.9% | ||
| Q4 24 | 0.1% | -8.0% | ||
| Q3 24 | 5.9% | -2.7% | ||
| Q2 24 | 6.2% | -7.7% | ||
| Q1 24 | 7.5% | -5.6% |
净利率ASTHFTRE
| Q4 25 | 0.7% | -4.9% | ||
| Q3 25 | 0.0% | -2.3% | ||
| Q2 25 | 1.4% | -52.8% | ||
| Q1 25 | 1.1% | -86.4% | ||
| Q4 24 | -1.2% | -8.8% | ||
| Q3 24 | 3.4% | -4.1% | ||
| Q2 24 | 3.9% | -20.9% | ||
| Q1 24 | 3.7% | -15.3% |
每股收益（稀释后）ASTHFTRE
| Q4 25 | $0.12 | $-0.25 | ||
| Q3 25 | $0.01 | $-0.17 | ||
| Q2 25 | $0.19 | $-4.14 | ||
| Q1 25 | $0.14 | $-6.25 | ||
| Q4 24 | $-0.14 | $-0.68 | ||
| Q3 24 | $0.33 | $-0.31 | ||
| Q2 24 | $0.40 | $-1.55 | ||
| Q1 24 | $0.31 | $-1.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $174.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $563.5M |
| 总资产 | $2.2B | $2.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHFTRE
| Q4 25 | $429.5M | $174.6M | ||
| Q3 25 | $463.4M | $131.3M | ||
| Q2 25 | $342.1M | $81.2M | ||
| Q1 25 | $260.9M | $101.6M | ||
| Q4 24 | $290.8M | $118.5M | ||
| Q3 24 | $350.3M | $105.3M | ||
| Q2 24 | $327.7M | $126.2M | ||
| Q1 24 | $337.3M | $92.8M |
股东权益ASTHFTRE
| Q4 25 | $779.3M | $563.5M | ||
| Q3 25 | $775.5M | $580.8M | ||
| Q2 25 | $765.5M | $589.2M | ||
| Q1 25 | $745.4M | $858.8M | ||
| Q4 24 | $712.7M | $1.4B | ||
| Q3 24 | $704.6M | $1.5B | ||
| Q2 24 | $678.9M | $1.5B | ||
| Q1 24 | $653.5M | $1.6B |
总资产ASTHFTRE
| Q4 25 | $2.2B | $2.7B | ||
| Q3 25 | $2.2B | $2.7B | ||
| Q2 25 | $1.4B | $2.8B | ||
| Q1 25 | $1.3B | $3.1B | ||
| Q4 24 | $1.4B | $3.6B | ||
| Q3 24 | $1.3B | $3.7B | ||
| Q2 24 | $1.3B | $3.6B | ||
| Q1 24 | $1.2B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $129.1M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $121.6M |
| 自由现金流率自由现金流/营收 | -0.6% | 18.4% |
| 资本支出强度资本支出/营收 | 0.3% | 1.1% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $88.3M |
8季度趋势，按日历期对齐
经营现金流ASTHFTRE
| Q4 25 | $-2.9M | $129.1M | ||
| Q3 25 | $10.0M | $86.8M | ||
| Q2 25 | $90.9M | $21.8M | ||
| Q1 25 | $16.6M | $-124.2M | ||
| Q4 24 | $-10.9M | $17.1M | ||
| Q3 24 | $34.0M | $-2.4M | ||
| Q2 24 | $23.2M | $273.7M | ||
| Q1 24 | $6.0M | $-25.6M |
自由现金流ASTHFTRE
| Q4 25 | $-6.0M | $121.6M | ||
| Q3 25 | $7.4M | $79.5M | ||
| Q2 25 | $89.5M | $14.3M | ||
| Q1 25 | $13.6M | $-127.1M | ||
| Q4 24 | $-13.5M | $13.9M | ||
| Q3 24 | $31.7M | $-10.6M | ||
| Q2 24 | $20.4M | $262.5M | ||
| Q1 24 | $5.6M | $-34.9M |
自由现金流率ASTHFTRE
| Q4 25 | -0.6% | 18.4% | ||
| Q3 25 | 0.8% | 11.3% | ||
| Q2 25 | 13.7% | 2.0% | ||
| Q1 25 | 2.2% | -19.5% | ||
| Q4 24 | -2.0% | 2.0% | ||
| Q3 24 | 6.6% | -1.6% | ||
| Q2 24 | 4.2% | 39.6% | ||
| Q1 24 | 1.4% | -5.3% |
资本支出强度ASTHFTRE
| Q4 25 | 0.3% | 1.1% | ||
| Q3 25 | 0.3% | 1.0% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 0.5% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.6% | 1.7% | ||
| Q1 24 | 0.1% | 1.4% |
现金转化率ASTHFTRE
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FTRE
暂无分部数据
